Anandamide Is a Potential Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis.
作者信息
Cinar Resat, Basu Abhishek, Arif Muhammad, Park Joshua K, Zawatsky Charles N, Zuo Ben Long G, Zuo Mei Xing G, O'Brien Kevin J, Behan Molly, Introne Wendy, Iyer Malliga R, Gahl William A, Malicdan May Christine V, Gochuico Bernadette R
机构信息
Section on Fibrotic Disorders.
Laboratory of Cardiovascular Physiology and Tissue Injury.
出版信息
Am J Respir Crit Care Med. 2025 Apr;211(4):650-654. doi: 10.1164/rccm.202406-1143RL.
Abstract
摘要
相似文献
1
Anandamide Is a Potential Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis.花生四烯乙醇胺是Hermansky-Pudlak综合征相关性肺纤维化的潜在血液生物标志物。
Am J Respir Crit Care Med. 2025 Apr;211(4):650-654. doi: 10.1164/rccm.202406-1143RL.
3
A case of hermansky-pudlak syndrome with pulmonary sarcoidosis.一例合并肺结节病的Hermansky-Pudlak综合征患者。
J Clin Aesthet Dermatol. 2009 Oct;2(10):41-4.
4
[Familial pulmonary fibrosis in 2 Mexican sisters with Hermansky-Pudlak syndrome].[两名患有Hermansky-Pudlak综合征的墨西哥姐妹中的家族性肺纤维化]
Arch Bronconeumol. 2009 Aug;45(8):408-10. doi: 10.1016/j.arbres.2009.01.002. Epub 2009 May 2.
5
Hermansky-Pudlak Syndrome: An unusual pattern of pulmonary fibrosis.赫尔曼斯基-普德拉克综合征：一种不寻常的肺纤维化模式。
Respir Med Case Rep. 2024 Sep 26;52:102123. doi: 10.1016/j.rmcr.2024.102123. eCollection 2024.
6
Hermansky-Pudlak syndrome: radiography and CT of the chest compared with pulmonary function tests and genetic studies.Hermansky-Pudlak综合征：胸部X线摄影及CT与肺功能检查和基因研究的比较
AJR Am J Roentgenol. 2002 Oct;179(4):887-92. doi: 10.2214/ajr.179.4.1790887.
7
Anandamide is an Early Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis.花生四烯乙醇胺是Hermansky-Pudlak综合征相关性肺纤维化的早期血液生物标志物。
medRxiv. 2024 May 17:2024.05.16.24307300. doi: 10.1101/2024.05.16.24307300.
8
Characterization of melanosomes in murine Hermansky-Pudlak syndrome: mechanisms of hypopigmentation.小鼠Hermansky-Pudlak综合征中黑素小体的特征：色素减退的机制
J Invest Dermatol. 2004 Feb;122(2):452-60. doi: 10.1046/j.0022-202X.2004.22117.x.
9
Hermansky-Pudlak syndrome: Gene therapy for pulmonary fibrosis.Hermansky-Pudlak 综合征：肺纤维化的基因治疗。
Mol Genet Metab. 2022 Sep-Oct;137(1-2):187-191. doi: 10.1016/j.ymgme.2022.08.008. Epub 2022 Sep 2.
10
Identification of a novel mutation in HPS6 in a patient with hemophilia B and oculocutaneous albinism.一名患有乙型血友病和眼皮肤白化病患者中HPS6新突变的鉴定。
Mol Genet Metab. 2016 Nov;119(3):284-287. doi: 10.1016/j.ymgme.2016.08.009. Epub 2016 Sep 3.
引用本文的文献
1
Targeting cannabinoid receptor 1 for antagonism in pro-fibrotic alveolar macrophages mitigates pulmonary fibrosis.靶向大麻素受体1以拮抗促纤维化肺泡巨噬细胞可减轻肺纤维化。
JCI Insight. 2025 Jul 3;10(15). doi: 10.1172/jci.insight.187967. eCollection 2025 Aug 8.
2
Elevated blood anandamide levels in acute COVID-19 pneumonia with respiratory failure.急性COVID-19肺炎合并呼吸衰竭患者血中花生四烯酸乙醇胺水平升高。
Am J Med Sci. 2025 Jun 4. doi: 10.1016/j.amjms.2025.06.003.
3
Age-related neutrophil activation in Hermansky-Pudlak Syndrome Type-1.1型赫尔曼斯基-普德拉克综合征中与年龄相关的中性粒细胞活化
Orphanet J Rare Dis. 2025 May 12;20(1):226. doi: 10.1186/s13023-025-03758-5.
本文引用的文献
1
CB R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky-Pudlak syndrome.CB R 和 iNOS 是促进 Hermansky-Pudlak 综合征肺纤维化的两个不同的角色。
Clin Transl Med. 2021 Jul;11(7):e471. doi: 10.1002/ctm2.471.
2
Hermansky-Pudlak Syndrome and Lung Disease: Pathogenesis and Therapeutics.赫尔曼斯基-普德拉克综合征与肺部疾病：发病机制与治疗方法
Front Pharmacol. 2021 Mar 18;12:644671. doi: 10.3389/fphar.2021.644671. eCollection 2021.
3
Hermansky-Pudlak syndrome pulmonary fibrosis: a rare inherited interstitial lung disease.Hermansky-Pudlak 综合征肺纤维化：一种罕见的遗传性间质性肺疾病。
Eur Respir Rev. 2021 Feb 2;30(159). doi: 10.1183/16000617.0193-2020. Print 2021 Mar 31.
4
The therapeutic potential of second and third generation CBR antagonists.第二代和第三代 CBR 拮抗剂的治疗潜力。
Pharmacol Ther. 2020 Apr;208:107477. doi: 10.1016/j.pharmthera.2020.107477. Epub 2020 Jan 9.
5
Bleomycin Induces Drug Efflux in Lungs. A Pitfall for Pharmacological Studies of Pulmonary Fibrosis.博来霉素诱导肺部药物外排。肺纤维化药物研究的一个陷阱。
Am J Respir Cell Mol Biol. 2020 Feb;62(2):178-190. doi: 10.1165/rcmb.2018-0147OC.
6
Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis.大麻素CB1受体活性过高会导致特发性肺纤维化的发病。
JCI Insight. 2017 Apr 20;2(8). doi: 10.1172/jci.insight.92281.
7
Hermansky-Pudlak Syndrome.赫尔曼斯基-普德拉克综合征
Clin Chest Med. 2016 Sep;37(3):505-11. doi: 10.1016/j.ccm.2016.04.012. Epub 2016 Jun 30.
8
Dysregulation of galectin-3. Implications for Hermansky-Pudlak syndrome pulmonary fibrosis.半乳糖凝集素-3 的失调。对 Hermansky-Pudlak 综合征肺纤维化的影响。
Am J Respir Cell Mol Biol. 2014 Mar;50(3):605-13. doi: 10.1165/rcmb.2013-0025OC.
9
Automated quantification of high-resolution CT scan findings in individuals at risk for pulmonary fibrosis.高分辨率 CT 扫描在肺纤维化高危人群中的应用。
Chest. 2011 Dec;140(6):1590-1597. doi: 10.1378/chest.10-2545. Epub 2011 May 26.
10
Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1.因HPS-1基因突变导致的遗传性肺纤维化患者（Hermansky-Pudlak综合征）的肺功能及高分辨率CT表现
Chest. 2000 Jan;117(1):129-36. doi: 10.1378/chest.117.1.129.
Zotero 插件